Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Charehbili, A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(41)
+
-
Availability
Open access
(2)
+
-
Some under embargo
(1)
+
-
Metadata Only
(40)
+
-
Creation Date
2015
(11)
+
-
2016
(10)
+
-
2013
(8)
+
-
2014
(6)
+
-
2017
(3)
+
-
2019
(3)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(42)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(42)
+
-
Topic
Breast cancer
(12)
+
-
Zoledronic acid
(5)
+
-
Neoadjuvant
(4)
+
-
Neoadjuvant chemotherapy
(4)
+
-
Chemotherapy
(3)
+
-
Pathological complete response
(3)
+
-
breast cancer
(3)
+
-
Aromatase inhibitors
(2)
+
-
Bisphosphonates
(2)
+
-
Endocrine therapy
(2)
+
-
IGF-1R
(2)
+
-
Insulin
(2)
+
-
Surgery
(2)
+
-
neoadjuvant
(2)
+
-
neoadjuvant chemotherapy
(2)
+
-
pCR
(2)
+
-
Show more
Author
Charehbili, A.
(43)
+
-
Kroep, J.R.
(37)
+
-
Velde, C.J.H. van de
(29)
+
-
Liefers, G.J.
(23)
+
-
Nortier, J.W.R.
(22)
+
-
Smit, V.T.H.B.M.
(19)
+
-
Putter, H.
(16)
+
-
Kranenbarg, E.M.K.
(12)
+
-
Laarhoven, H.W.M. van
(10)
+
-
Heijns, J.B.
(9)
+
-
Kuppen, P.J.K.
(8)
+
-
Blok, E.J.
(7)
+
-
Groot, S. de
(7)
+
-
Leeuwen-Stok, A.E. van
(7)
+
-
Pijl, H.
(7)
+
-
Ven, S. van de
(7)
+
-
Fontein, D.B.Y.
(6)
+
-
Hoeven, J.J.M. van der
(6)
+
-
Kessels, L.
(6)
+
-
Kessels, L.W.
(6)
+
-
Wasser, M.N.
(5)
+
-
Brussel, A. van
(4)
+
-
Dekker, T.J.A.
(4)
+
-
Dekker-Ensink, N.G.
(4)
+
-
Hamdy, N.A.T.
(4)
+
-
Janssen, L.G.M.
(4)
+
-
Maartense, E.
(4)
+
-
Mesker, W.E.
(4)
+
-
Seynaeve, C.M.
(4)
+
-
Stolpe, A. van de
(4)
+
-
Tollenaar, R.A.E.M.
(4)
+
-
Verhaegh, W.
(4)
+
-
Vriens, B.
(4)
+
-
Biezen, E. den
(3)
+
-
Bochove, A. van
(3)
+
-
Dercksen, W.
(3)
+
-
Dutch Breast Canc Res Grp BOOG
(3)
+
-
Engels, C.C.
(3)
+
-
Fruytier, S.
(3)
+
-
Guchelaar, H.J.
(3)
+
-
Inda, M.A. de
(3)
+
-
Kranenbarg, E.M.M.K.
(3)
+
-
Linn, S.C.
(3)
+
-
Martens, J.W.M.
(3)
+
-
Nortier, H.W.R.
(3)
+
-
Pepels, M.J.
(3)
+
-
Smit, V.T.
(3)
+
-
Swen, J.J.
(3)
+
-
Vahrmeijer, A.L.
(3)
+
-
Velde, C.J.H.V. de
(3)
+
-
Wasser, M.N.J.M.
(3)
+
-
Aft, R.L.
(2)
+
-
Akazawa, K.
(2)
+
-
Boer, M. de
(2)
+
-
Bos, M.M.E.M.
(2)
+
-
Bremer, J. van den
(2)
+
-
Burg, S.H. van der
(2)
+
-
Chan, A.
(2)
+
-
Coleman, R.E.
(2)
+
-
Dijkgraaf, E.M.
(2)
+
-
Dijkstra, J.
(2)
+
-
Dutch Breast Canc Res Grp
(2)
+
-
Foekens, J.A.
(2)
+
-
Gelderblom, H.
(2)
+
-
Giessen, M.V. de
(2)
+
-
Gijn, W. van
(2)
+
-
Gratama, J.W.
(2)
+
-
Groot, A.F. de
(2)
+
-
Hasegawa, Y.
(2)
+
-
Hinsley, S.
(2)
+
-
Kohno, N.
(2)
+
-
Kraan, J.
(2)
+
-
Kranenbarg, W.M.M.K.
(2)
+
-
Leeuwen-Stok, E. van
(2)
+
-
Lelieveldt, B.P.F.
(2)
+
-
Lowik, W.G.M.
(2)
+
-
Mooyaart, A.L.
(2)
+
-
Mostert, B.
(2)
+
-
Onstenk, W.
(2)
+
-
Peer, P.G.
(2)
+
-
Schaafsma, B.E.
(2)
+
-
Sieuwerts, A.M.
(2)
+
-
Sleijfer, S.
(2)
+
-
Straaten, T. van der
(2)
+
-
Swijnenburg, R.J.
(2)
+
-
Vriens, B.E.P.J.
(2)
+
-
Warmerdam, L.J. van
(2)
+
-
Warmerdam, L.J.C. van
(2)
+
-
Winter, M.C.
(2)
+
-
Show more
Language
en
(43)
+
-
Search results
(1 - 24 of 43)
Pages
1
2
›
››
show grid
show list
save search
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer
Estrogen receptor pathway activity score to predict clinical response or resistance to neoadjuvant endocrine therapy in primary breast cancer
Cluster-randomized crossover trial of chlorhexidine-alcohol versus iodine-alcohol for prevention of surgical-site infection (SKINFECT trial)
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Tumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial
Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
Serum vit D levels and response to molecular subtypes in breast cancer Reply
Concordance of folate receptor-alpha expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
ER pathway activity as a predictive biomarker for neoadjuvant endocrine therapy
Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)
ER pathway activity as a predictive biomarker for neoadjuvant endocrine therapy
ER pathway activity as a predictive biomarker for neoadjuvant endocrine therapy
Radiological evaluation of neo-adjuvant endocrine therapy in hormone-receptor positive early breast cancer
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia
Optimising preoperative systemic therapy for breast cancer
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial
Sentinel node procedure before or after neoadjuvant chemotherapy in clinically node negative or positive patients; results from 3 phase III studies of the Dutch breast cancer trialists' group (BOOG)
Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
Thyroid function is associated with the response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial on behalf of the Dutch Breast Cancer Research Group (BOOG 2010-01)
Pages
1
2
›
››